Plumbline Life Sciences, Inc.
Develops DNA vaccines and therapeutics for companion animals and livestock.
222670 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 반포대로 222성의교정 성의회관 1315호, 서울특별시
- Website:
- http://www.plsdna.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Plumbline Life Sciences, Inc. is an animal biopharmaceutical company that develops a new class of nucleic acid-based DNA medicines. Utilizing its proprietary DNA platform technology, the company creates vaccines and therapeutics for the global animal health market, targeting both companion animals and livestock. Its development pipeline includes 'Renewdog', a first-in-class DNA therapeutic for canines, and other products for applications such as oncology and infectious disease prevention. The company's technology is designed to produce potent, safe, and room-temperature stable treatments with a simplified manufacturing process.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-06-12 00:00 |
Regulatory News Service
기업설명회(IR)개최결과
|
Korean | 6.6 KB | ||
| 2025-06-11 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시)
|
Korean | 5.3 KB | ||
| 2025-06-02 00:00 |
Share Issue/Capital Change
주요사항보고서(유상증자결정)
|
Korean | 32.5 KB | ||
| 2025-05-29 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 7.0 KB | ||
| 2025-05-16 00:00 |
Share Issue/Capital Change
[기재정정]전환청구권행사
|
Korean | 19.7 KB | ||
| 2025-05-12 00:00 |
Share Issue/Capital Change
전환청구권행사
|
Korean | 16.5 KB | ||
| 2025-04-28 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 40.7 KB | ||
| 2025-04-07 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 41.6 KB | ||
| 2025-04-07 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 40.2 KB | ||
| 2025-04-03 00:00 |
Transaction in Own Shares
자기주식처분결과보고서
|
Korean | 18.3 KB | ||
| 2025-03-28 00:00 |
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
|
Korean | 31.1 KB | ||
| 2025-03-26 00:00 |
Post-Annual General Meeting Information
정기주주총회결과
|
Korean | 17.9 KB | ||
| 2025-03-26 00:00 |
Remuneration Information
주식매수선택권부여에관한신고
|
Korean | 20.6 KB | ||
| 2025-03-20 00:00 |
Share Issue/Capital Change
증권발행결과(자율공시) (제3자배정 유상증자)
|
Korean | 5.6 KB | ||
| 2025-03-19 00:00 |
Audit Report / Information
사업보고서 (2024.12)
|
Korean | 299.7 KB |
Automate Your Workflow. Get a real-time feed of all Plumbline Life Sciences, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Plumbline Life Sciences, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
